BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
181 hedge funds and large institutions have $2.84B invested in Blueprint Medicines in 2018 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 74 increasing their positions, 45 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
181
Holders Change
+6
Holders Change %
+3.43%
% of All Funds
4.15%
Holding in Top 10
7
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-41.67%
% of All Funds
0.16%
New
36
Increased
74
Reduced
45
Closed
30
Calls
$37.1M
Puts
$21.4M
Net Calls
+$15.7M
Net Calls Change
+$15.5M
Top Buyers
| 1 |
1
Fidelity International
Hamilton,
Bermuda
|
$47.2M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$117M |
| 3 |
CC
3
Casdin Capital
New York
|
$40.3M |
| 4 |
4
Two Sigma Investments
New York
|
$22.1M |
| 5 |
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$26M |
